SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-258369
Filing Date
2015-07-21
Accepted
2015-07-21 16:07:02
Documents
4
Period of Report
2015-07-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d64149d8k.htm 8-K 19320
2 EX-1.1 d64149dex11.htm EX-1.1 185980
3 EX-5.1 d64149dex51.htm EX-5.1 7223
4 GRAPHIC g64149g73t85.jpg GRAPHIC 2214
  Complete submission text file 0001193125-15-258369.txt   216804
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36276 | Film No.: 15997955
SIC: 2834 Pharmaceutical Preparations